首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1347567

分子诊断市场：2023-2028 年全球行业趋势、份额、规模、增长、机会和预测

Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年09月04日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

市场概况：

2022年全球分子诊断市场规模达到185亿美元。展望未来，IMARC集团预计到2028年市场规模将达到274亿美元，2023-2028年復合年增长率（CAGR）为6.5%。

分子诊断是指对个体的脱氧核糖核酸 (DNA)、核糖核酸 (RNA) 或细胞蛋白进行测序以分析潜在疾病的生物标誌物的一组实验室测试。它有助于诊断和监测感染和疾病、检测风险以及评估治疗反应。近年来，分子诊断在肿瘤学、药物基因组学、微生物学、传染病、遗传病筛查和血液筛查等领域迅速受到关注。随着最近的进步，分子诊断已成为针对患者的干预和治疗的重要方面，这正在全球范围内不断增加其需求。

分子诊断市场趋势：

分子诊断广泛应用于医院、实验室和研究机构，用于疾病的早期检测、凝血和人类白细胞抗原分型。因此，癌症、心血管疾病（CVD）、神经系统疾病和传染病等慢性病患病率的上升是推动市场增长的主要因素。除此之外，越来越多的老年人口更容易患上多种医疗疾病，以及现场护理 (POC) 测试设备的广泛采用，正在刺激产品需求。此外，最近爆发的冠状病毒病 (COVID-19) 加速了分子诊断方法的采用，例如聚合酶链反应 (PCR)，用于 COVID-19 检测。与此同时，各国管理机构和监管机构采取的多项有利倡议，例如快速批准诊断产品以帮助遏制病毒传播，也推动了市场增长。此外，领先企业正在投入巨资推出创新的诊断设备，这些设备可提供更高的准确性、灵活性、成本效益和更快的结果，以扩大其产品组合併获得竞争优势。其他因素，包括个性化治疗需求的不断增长、预防医学的新兴趋势、医疗基础设施的改善和技术进步，也创造了积极的市场前景。

本报告回答的关键问题：

迄今为止，全球分子诊断市场表现如何，未来几年将如何表现？
COVID-19 对全球分子诊断市场有何影响？
主要区域市场有哪些？
基于产品的市场细分是什么？
基于技术的市场细分是什么？
基于应用程序的市场细分是什么？
基于最终用户的市场细分是什么？
行业价值链的各个阶段是什么？
该行业的关键驱动因素和挑战是什么？
全球分子诊断市场的结构如何？谁是主要参与者？
行业竞争程度如何？

北美
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳大利亚
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉美
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 11 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 12 章：价值链分析

第 13 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 14 章：价格分析

第15章：竞争格局

市场结构
关键参与者
关键参与者简介
- Abbott Laboratories
- Agilent Technologies Inc.
- Becton Dickinson and Company
- Biomerieux SA
- Danaher Corporation
- Diasorin Molecular LLC (DiaSorin SpA)
- F. Hoffmann-La Roche AG (Roche Holding AG)
- Hologic Inc.
- Illumina Inc.
- Myriad Genetics Inc.
- Qiagen
- Quidel Corporation
- Thermo Fisher Scientific

简介目录图表

Product Code: SR112023A5726

Market Overview:

The global molecular diagnostics market size reached US$ 18.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.

Molecular diagnostics refers to a set of laboratory tests that sequences the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or cell proteins of an individual to analyze biomarkers of potential diseases. It assists in diagnosing and monitoring infections and diseases, detecting risks, and assessing therapy response. In recent years, molecular diagnostics has rapidly gained traction in oncology, pharmacogenomics, microbiology, infectious diseases, genetic disease screening, and blood screening. With recent advancements, molecular diagnostics has become an essential aspect of patient-tailored interventions and therapeutics, which is escalating its demand across the globe.

Molecular Diagnostics Market Trends:

Molecular diagnostics is widely used by hospitals, laboratories, and research institutes for early detection of diseases, coagulation, and human leukocyte antigen typing. As a result, the rising prevalence of chronic conditions, such as cancer, cardiovascular diseases (CVDs), neurological disorders, and infectious diseases, represents the primary factor driving the market growth. Besides this, the growing geriatric population that is more susceptible to developing numerous medical ailments and the widespread adoption of point-of-care (POC) testing devices are catalyzing the product demand. Additionally, the recent outbreak of coronavirus disease (COVID-19) has accelerated the adoption of molecular diagnostic methods, such as polymerase chain reaction (PCR), for COVID-19 testing. Along with this, several favorable initiatives undertaken by the governing agencies and regulatory authorities of various countries, such as fast approvals of diagnostic products to help curb the spread of the virus, are also propelling the market growth. Furthermore, the leading players are making heavy investments to launch innovative diagnostic devices that offer enhanced accuracy, flexibility, cost-effectiveness, and faster results to expand their product portfolio and gain a competitive edge. Other factors, including the escalating demand for personalized treatment, the emerging trend of preventive medicine, improving healthcare infrastructure, and technological advancements, are also creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end users.

Breakup by Product:

Reagents and Kits

Instruments

Software and Services

Breakup by Technology:

Polymerase Chain Reactions (PCR)

Hybridization

DNA Sequencing

Microarray

Isothermal Nucleic Acid Amplification Technology (INAAT)

Others

Breakup by Application:

Infectious Diseases Diagnostics

Oncology

Genetic Testing

Blood Screening

Others

Breakup by End Users:

Hospitals

Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific.

Key Questions Answered in This Report:

How has the global molecular diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global molecular diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end users?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global molecular diagnostics market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Molecular Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Reagents and Kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Polymerase Chain Reactions (PCR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Hybridization
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 DNA Sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Microarray
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Infectious Diseases Diagnostics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Oncology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Genetic Testing
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Blood Screening
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End Users

9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Agilent Technologies Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Becton Dickinson and Company
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Biomerieux SA
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Danaher Corporation
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Diasorin Molecular LLC (DiaSorin S.p.A.)
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 F. Hoffmann-La Roche AG (Roche Holding AG)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 SWOT Analysis
- 15.3.8 Hologic Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Illumina Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Myriad Genetics Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Qiagen
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Quidel Corporation
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis
- 15.3.13 Thermo Fisher Scientific
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio
  - 15.3.13.3 Financials
  - 15.3.13.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2022
Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2022
Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2022
Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2022
Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2022
Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2022
Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million US$), 2023-2028
Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Molecular Diagnostics Market: Competitive Structure
Table 8: Global: Molecular Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219